Assessment of physical functioning and handling of Spiolto® Respimat® in patients with chronic obstructive pulmonary disease (COPD) requiring long-acting dual bronchodilation in routine clinical practice (OTIVACTO SPAIN)

First published 09/06/2016

Last updated 28/09/2026

EU PAS number:

EUPAS13754

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

1237.58_CTP.pdf

English (559.57 KB - PDF) View document

Study results

OTIVACTO_Redacted Summary Results

English (237.8 KB - PDF) View document

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Assessment of physical functioning and handling of Spiolto® Respimat® in patients with chronic obstructive pulmonary disease (COPD) requiring long-acting dual bronchodilation in routine clinical practice (OTIVACTO SPAIN)

Secondary tabs

Share this page